President Biden has declared that the U.S. is endorsing a World Trade Organization scheme to force pharmaceutical companies to turn over American Covid-19 vaccine technology to any country or company that wants it. This, after these drug companies have spent billions of dollars and devoted immense brainpower and time to develop these vaccines in record time, thereby saving millions of lives.
The implications of the Biden move are ghastly. Washington is about to smash up one of our most innovative industries—and for no good reason.
To start with, such a theft won’t increase the output or availability of Covid-19 vaccines. The production process is immensely complex and cannot be rushed. The Washington Post—hardly a bastion of free-market principles—declared, “The most salient fact is that patents on vaccines are not the central bottleneck, and even if turned over to other nations, would not quickly result in more shots.”
Drug companies are ramping up production as quickly as possible while ensuring the vaccines’ safety. Global supplies will be tight for the next few months, but there will be more than 12 billion doses by the end of 2022.
Here’s the frightening reality if the Biden move isn’t reversed: Criminals and companies with lower standards will be injecting counterfeit or substandard vaccines into the marketplace.
It’s the long-term consequences that are so destructive, though. It takes $2.6 billion and a decade of research and testing to successfully bring a new drug to market. If new medical technologies can be seized by headline-hunting politicians, companies and investors aren’t going to commit the resources and take on the enormous risk of developing new medicines and medical devices. Why undergo such a process if hard-won success will be handed over to China and others on a silver platter?
This story is from the August 2021 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August 2021 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
BACK ON TRACK
Collective wealth gets a 21% boost to a record $162 billion amid an economic uptick.
Championing Locals
The wave of social commerce is enabling inclusive digital economies beyond urban areas.
Gold Rallies on Inflation Fears
During September the price of gold rallied to $1,868 per ounce following the release of figures on US inflation by the Bureau of Labor Statistics which indicated that, as of September, CPI inflation had rocketed to 6.2%, above the 5.8% which economists had been predicting.
THE CROESUS OF CRYPTO
FTX COFOUNDER SAM BANKMAN-FRIED BUILT A $22.5 BILLION FORTUNE BEFORE HIS 30TH BIRTHDAY BY PROFITING OFF THE CRYPTOCURRENCY FRENZY—BUT HE’S NOT A TRUE BELIEVER. HE JUST WANTS HIS WEALTH TO SURVIVE LONG ENOUGH TO GIVE IT ALL AWAY.
The Cost of Looking Good
The fashion industry is at the tipping point of turning sustainable.
Resilient Sectors in Greater Jakarta Amid the Pandemic
The pandemic has resulted in a challenging period for much of the Greater Jakarta real estate market.
Sweet Dream
On 17 August 2021, PTPN, the national state-owned plantation company, with government support, officially established PT Sinergi Gula Nusantara (SugarCo) by bringing together 35 sugar mills owned by seven of its members under a single entity subsidiary.
To the Moon
Tokocrypto takes early steps to integrate blockchain and crypto technology into Indonesian society
Charting the New Streams
As a podcast content platform, Noice is starting to show substantial growth in the Indonesian market by focusing on local content and multi-vertical audio.
Race to Zero
Katingan Mentaya Project is leading the way in the global carbon finance-based conservation.